Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Kintor Pharmaceutical Ltd ( (HK:9939) ) has provided an announcement.
Kintor Pharmaceutical Limited has announced changes to its Nomination Committee, effective June 26, 2025. Dr. Youzhi Tong has stepped down as chairman and member, with Ms. Geqi Wei joining as a member and Dr. Michael Min Xu taking over as chairman. These changes, along with revisions to the committee’s terms of reference, aim to enhance corporate governance and diversity, aligning with upcoming updates to the Corporate Governance Code.
More about Kintor Pharmaceutical Ltd
Kintor Pharmaceutical Limited is a company incorporated in the Cayman Islands, operating within the pharmaceutical industry. It focuses on developing innovative therapies and has a market presence in Hong Kong, where it is publicly listed.
Average Trading Volume: 2,918,958
Technical Sentiment Signal: Buy
Current Market Cap: HK$691.3M
See more insights into 9939 stock on TipRanks’ Stock Analysis page.